SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-18-004308
Filing Date
2018-05-24
Accepted
2018-05-24 07:06:06
Documents
5
Period of Report
2018-05-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s110252_8k.htm 8-K 22275
2 EXHIBIT 4.1 s110252_ex4-1.htm EX-4.1 1411
3 EXHIBIT 99.01 s110252_ex99-01.htm EX-99.01 15486
4 GRAPHIC img001_v1.jpg GRAPHIC 111857
5 GRAPHIC img002_v1.jpg GRAPHIC 104532
  Complete submission text file 0001615774-18-004308.txt   338648
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 18856625
SIC: 2834 Pharmaceutical Preparations